“Using Supercomputing & Advanced Analytic Software to Discover Radical Changes in the Human Microbiome in Health and Disease” Invited Remote Presentation.

Slides:



Advertisements
Similar presentations
A Systems Approach to Personalized Medicine Talk and Discussion NASA Ames Mountain View, CA March 28, 2013 Dr. Larry Smarr Director, California Institute.
Advertisements

Reading Out the State of the Body and How it Changes Under Therapy Guest Lecture Pharmacy Informatics 2013 University of California San Diego June 7, 2013.
Large Memory High Performance Computing Enables Comparison Across Human Gut Microbiome of Patients with Autoimmune Diseases and Healthy Subjects XSEDE.
Deep Self - Quantifying the State of Your Body Invited Talk NextMed / MMVR20 San Diego February 21, 2013 Dr. Larry Smarr Director, California Institute.
“Tracking Immune Biomarkers and the Human Gut Microbiome: Inflammation, Crohn's Disease, and Colon Cancer” USC Monthly Seminar Series Physical Sciences.
Exploring Our Inner Universe Using Supercomputers and Gene Sequencers Physics Department Colloquium UC San Diego October 24, 2013 Dr. Larry Smarr Director,
Discussion Janssen La Jolla Research and Development La Jolla, CA
Leveraging Biomedical Big Data: Quantified Self & Beyond Invited Talk FutureMed Singularity University NASA Ames Campus February 5, 2013 Dr. Larry Smarr.
The Microbiome: What’s the immune system got to do with it?
“The Systems Biology Dynamics of the Human Immune System and Gut Microbiome” Invited Talk UCI Systems Biology Seminar Series Irvine, CA October 14, 2013.
“Using Data Analytics to Discover the 100 Trillion Bacteria Living Within Each of Us” Invited Talk New Applications of Computer Analysis to Biomedical.
“Finding the Patterns in the Big Data From Human Microbiome Ecology” Invited Talk Exponential Medicine November 10, 2014 Dr. Larry Smarr Director, California.
The NIH Human Microbiome Project
“Personalized Medicine, Colorectal Cancer and Gut Bacteria”
The Microbiome and Metagenomics
Correlation Between Bacteria and Inflammatory Bowel Diseases
“Quantifying Your Superorganism Body Using Big Data Supercomputing” Ken Kennedy Institute Distinguished Lecture Rice University Houston, TX November 12,
Building a Community Cyberinfrastructure to Support Marine Microbial Ecology Metagenomics Center for Earth Observations and Applications Advisory Committee.
“The Quantified Self Movement: The Technologies That Are Revolutionizing Health and Fitness” Panel Discussion MIT Enterprise Forum San Diego UC San Diego.
“Discovering the Other 90% of our Human Superorganism” Remote Video Lecture to The eResearch Australasia Conference 2014 Melbourne, Australia October 28,
“Inflammation, Gut Microbiome, Bacteriophages, and the Initiation of Colorectal Cancer” Seminar Lecture City of Hope Pasadena, CA October 20, 2014 Dr.
My N=1 Experience Pioneer Session: "N=1: Pioneers of Self-Tracking“ Panel at the Genomes, Environment, and Traits Conference Harvard Medical School Cambridge,
“Mapping the Human Gut Microbiome in Health and Disease Using Sequencing, Supercomputing, and Data Analysis” Invited Talk Delivered by Mehrdad Yazdani,
“The Quantified Self: From Idiosyncratic Hobby to an Emerging Growth Industry” Invited Lecture Science & Technology Discovery Series Technology Alliance.
"Towards Digitally Enabled Genomic Medicine" Distinguished Lecture Series Department of Computer Science and Engineering UC San Diego October 15, 2012.
“Measuring the Human Brain-Gut Microbiome-Immune System Dynamics: a Big Data Challenge” Plenary Talk 45 th Annual Meeting of the Behavior Genetics Association.
“The Digital Transformation of Healthcare”
Inflammatory Bowel Disease Francisco A. Sylvester, MD Associate Professor of Pediatrics.
“Big Data and Superorganism Genomics – Microbial Metagenomics Meets Human Genomics” NGS and the Future of Medicine Illumina Headquarters La Jolla, CA February.
“Quantifying The Dynamics of Your Superorganism Body Using Big Data Supercomputing” Distinguished Lecturer Series Computer Science and Engineering.
“The Deeply Quantified Self: A Case Study” Future Technology Keynote Minimally Invasive Surgery Week 2015 Society of Laparoendoscopic Surgeons New York.
“Quantified Health and Disease” Lecture for the Osher Lifetime Learning Institute UCSD Extension Calit2’s Qualcomm Institute, UCSD La Jolla, CA February.
“Using Data Analytics to Discover the 100 Trillion Bacteria Living Within Each of Us” Invited Talk Ayasdi Menlo Park, CA December 5, 2014 Dr. Larry Smarr.
“Toward Novel Human Microbiome Surveillance Diagnostics to Support Public Health” Invited Talk Institute for Public Health University of California San.
“Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Inflammation, Crohn's Disease, and Colon Cancer” IBD Conference Speaker Series.
“Quantified Self- On Being a Personal Genomic Observatory” Keynote in the “Humans as Genomic Observatories” Meeting Session in the Genomics Standards Consortium.
“The Human Microbiome and the Revolution in Digital Health” The Florida Institute for Human and Machine Cognition Pensacola Evening Lecture Series Pensacola,
“Creating a High Performance Cyberinfrastructure to Support Analysis of Illumina Metagenomic Data” DNA Day Department of Computer Science and Engineering.
“Comparative Human Microbiome Analysis” Remote Video Talk to CICESE Big Data, Big Network Workshop Ensenada, Mexico October 10, 2013 Dr. Larry Smarr Director,
The Human Microbiome: PSC, IBD, and the Gut-Liver Axis
“Individual, Consumer-Driven Care of the Future -- Taking Wellness One Step Further” Closing Keynote Address The World Congress 2 nd Annual Leadership.
713 Lecture 15 Host metagenomics. Progression of techniques Culture based –Use phenotypes and genotypes to ID Non-culture based, focused on 16S rDNA –Clone.
“Inspired by Carl: Exploring the Microbial Dynamics Within” Invited Talk Looking in the Right Direction: Carl Woese and the New Biology University of Illinois,
“Living in a Microbial World” Global Health Program Council on Foreign Relations New York, NY April 10, 2014 Dr. Larry Smarr Director, California Institute.
“How Studying Astrophysics and Coral Reefs Enabled Me to Become an Empowered, Engaged Patient” Invited Talk FutureMed at the Hotel Del Coronado, CA November.
“Frontiers of Self-Tracking” Plenary Talk Quantified Self Conference 2012 Stanford University September 15, 2012 Dr. Larry Smarr Director, California Institute.
“Deciphering the Dynamic Coupling of the Human Immune System and the Gut Microbiome” Overview Data-Enabled Life Sciences Research (DELSA) DELSA Workshop.
“Observing the Dynamics of the Human Immune System Coupled to the Microbiome in Health and Disease” CASIS Workshop on Biomedical Research Aboard the ISS.
“Quantifying Your Superorganism Body Using Big Data Supercomputing” ACM International Workshop on Big Data in Life Sciences BigLS 2014 Newport Beach, CA.
“Assay Lab Within Your Body: Biometrics and Biomes” Invited Lecture TSensors Summit La Jolla, CA November 12, 2014 Dr. Larry Smarr Director, California.
“Discovering the Other 90% of our Human Superorganism” Remote Video Lecture to The eResearch Australasia Conference 2014 Melbourne, Australia October 28,
“Quantifying the Time Progression of the Interaction of the Human Immune System with the Gut Microbiome” Research Council Presentation UC San Diego Health.
“The UCSD Big Data Freeway System” Invited Short Talk Workshop on “Enriching Human Life and Society” UC San Diego February 6, 2014 Dr. Larry Smarr Director,
Lecture Science & Entertainment Exchange National Academy of Sciences Los Angeles June 13, 2013 Dr. Larry Smarr Director, California Institute for Telecommunications.
“Know Thyself: Quantifying Your Human Body and Its One Hundred Trillion Microbes” Understanding Cultures and Addressing Disparities in Society: Degrees.
“Using Genetic Sequencing to Unravel the Dynamics of Your Superorganism Body” Weekly Bioinformatics Seminar Series UC San Diego La Jolla, CA October 17,
“Adding Consumer-Generated and Microbiome Data to the Electronic Medical Record” Using Big Data to Advance Healthcare Panel National Health Policy Conference.
“Quantifying Your Dynamic Human Body (Including Its Microbiome), Will Move Us From a Sickcare System to a Healthcare System” Invited Presentation Microbiology.
Functional profiling with HUMAnN2
Keynote Presentation Cavendish Global Health Impact Forum
“Connecting Body Time Series to Macro Body Changes”
“Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Supercomputers and Supernetworks” Invited Presentation ESnet CrossConnects Bioinformatics.
“Linking Phenotype Changes to Internal/External Longitudinal Time Series in a Single Human” Invited Presentation at EMBC ‘16 38th International Conference.
“Machine Learning in Healthcare Diagnostics”
Briefing for Dell Analytics Team Calit2’s Qualcomm Institute
Invited Presentation Machine Learning in Healthcare
Metagenomics and Personalized Medicine
Volume 139, Issue 6, Pages e1 (December 2010)
Metagenomics and Personalized Medicine
Toward Accurate and Quantitative Comparative Metagenomics
Presentation transcript:

“Using Supercomputing & Advanced Analytic Software to Discover Radical Changes in the Human Microbiome in Health and Disease” Invited Remote Presentation To Weekly Team Meeting Dermot McGovern, Director, Translational Medicine, Inflammatory Bowel and Immunobiology Research Institute, Gastroenterology, Cedars-Sinai Los Angeles, CA April 28, 2015 Dr. Larry Smarr Director, California Institute for Telecommunications and Information Technology Harry E. Gruber Professor, Dept. of Computer Science and Engineering Jacobs School of Engineering, UCSD 1

I Discovered I Had IBD By Analyzing 150 Blood and Stool Variables, Each Over 5-10 Years Calit2 64 megapixel VROOM One Blood Draw For Me

Only One of My Blood Measurements Was Far Out of Range--Indicating Chronic Inflammation Normal Range <1 mg/L Normal 27x Upper Limit Complex Reactive Protein (CRP) is a Blood Biomarker for Detecting Presence of Inflammation Episodic Peaks in Inflammation Followed by Spontaneous Drops

Adding Stool Tests Revealed A Likelihood of My Having IBD Normal Range <7.3 µg/mL 124x Upper Limit Lactoferrin is a Glycoprotein Shed from Neutrophils - An Antibacterial that Sequesters Iron Typical Lactoferrin Value for Active IBD Hypothesis: Lactoferrin Oscillations Coupled to Relative Abundance of Microbes that Require Iron

Dynamical Innate and Adaptive Immune Oscillations From Stool Samples Normal <600 Innate Immune System Normal 50 to 200 Adaptive Immune System

Correlating Immune/Inflammation Time Series With Symptom/Sign, Pharmaceuticals, and Stool Metagenomics Time Series

I Found I Had One of the Earliest Known SNPs Associated with Crohn’s Disease From SNPs Associated with CD Polymorphism in Interleukin-23 Receptor Gene — 80% Higher Risk of Pro-inflammatory Immune Response rs NOD2 IRGM ATG16L1

There Is Likely a Correlation Between CD SNPs and Where and When the Disease Manifests Me-Male CD Onset At 60-Years Old Female CD Onset At 20-Years Old NOD2 (1) Rs x Increased Risk Il-23R Rs x Increased Risk Subject with Ileal Crohn’s Subject with Colonic Crohn’s Source: Larry Smarr and 23andme

A Statistical Study is Needed to Determine If NOD2 and IL23R Are Associated with Different Disease Phenotypes “Associations Between NOD2/CARD15 Genotype and Phenotype in Crohn’s Disease-Are We there Yet?,” Radford-Smith and Pandeya, World J. of Gastroentrology, 28, (2006)

I Also Had an Increased Risk for Ulcerative Colitis, But a SNP that is Also Associated with Colonic CD I Have a 33% Increased Risk for Ulcerative Colitis HLA-DRA (rs ) I Have the Same Level of HLA-DRA Increased Risk as Another Male Who Has Had Ulcerative Colitis for 20 Years “Our results suggest that at least for the SNPs investigated [including HLA-DRA], colonic CD and UC have common genetic basis.” -Waterman, et al., IBD 17, (2011)

So IBD May be Stratified by a Personalized Combination of the 163 Known SNPs Associated with IBD The width of the bar is proportional to the variance explained by that locus Bars are connected together if they are identified as being associated with both phenotypes Loci are labelled if they explain more than 1% of the total variance explained by all loci “Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease,” Jostins, et al. Nature 491, (2012) The Current Division of IBD Into Crohn’s Disease and Ulcerative Colitis May Turn Out to be Superseded by a More Accurate Human Genetic Stratification

To Map Out the Dynamics of Autoimmune Microbiome Ecology Couples Next Generation Genome Sequencers to Big Data Supercomputers Metagenomic Sequencing –JCVI Produced –~150 Billion DNA Bases From Seven of LS Stool Samples Over 1.5 Years –We Downloaded ~3 Trillion DNA Bases From NIH Human Microbiome Program Data Base –255 Healthy People, 21 with IBD Supercomputing (Weizhong Li, JCVI/HLI/UCSD): –~20 CPU-Years on SDSC’s Gordon –~4 CPU-Years on Dell’s HPC Cloud Produced Relative Abundance of –~10,000 Bacteria, Archaea, Viruses in ~300 People –~3Million Filled Spreadsheet Cells Illumina HiSeq 2000 at JCVI SDSC Gordon Data Supercomputer Example: Inflammatory Bowel Disease (IBD)

JCVI Sequenced My Gut Microbiome and We Downloaded ~270 More from the NIH Human Microbiome Project For Comparative Analysis 5 Ileal Crohn’s Patients, 3 Points in Time 2 Ulcerative Colitis Patients, 6 Points in Time “Healthy” Individuals Source: Jerry Sheehan, Calit2 Weizhong Li, Sitao Wu, CRBS, UCSD Total of 27 Billion Reads Or 2.7 Trillion Bases Inflammatory Bowel Disease (IBD) Patients 250 Subjects 1 Point in Time 7 Points in Time Each Sample Has Million Illumina Short Reads (100 bases) Larry Smarr (Colonic Crohn’s)

We Created a Reference Database Of Known Gut Genomes NCBI April 2013 –2471 Complete Draft Bacteria & Archaea Genomes –2399 Complete Virus Genomes –26 Complete Fungi Genomes –309 HMP Eukaryote Reference Genomes Total 10,741 genomes, ~30 GB of sequences Now to Align Our 27 Billion Reads Against the Reference Database Source: Weizhong Li, Sitao Wu, CRBS, UCSD

Computational NextGen Sequencing Pipeline: From Sequence to Taxonomy and Function PI: (Weizhong Li, CRBS, UCSD): NIH R01HG ( , $1.1M)

Next Step Programmability, Scalability and Reproducibility using bioKeplerwww.kepler-project.org National Resources (Gordon) (Comet) (Stampede) (Lonestar) Cloud Resources Optimized Local Cluster Resources Source: Ilkay Altintas, SDSC

Using Microbiome Profiles to Survey 155 Subjects for Unhealthy Candidates

We Found Major State Shifts in Microbial Ecology Phyla Between Healthy and Three Forms of IBD Most Common Microbial Phyla Average HE Average Ulcerative Colitis Average LS Colonic Crohn’s Disease Average Ileal Crohn’s Disease Collapse of Bacteroidetes Explosion of Actinobacteria Explosion of Proteobacteria Hybrid of UC and CD High Level of Archaea

Dell Analytics Separates The 4 Patient Types in Our Data Using Our Microbiome Species Data Source: Thomas Hill, Ph.D. Executive Director Analytics Dell | Information Management Group, Dell Software Healthy Ulcerative Colitis Colonic Crohn’s Ileal Crohn’s

Dell Analytics Tree Graphs Classifies the 4 Health/Disease States With Just 3 Microbe Species Source: Thomas Hill, Ph.D. Executive Director Analytics Dell | Information Management Group, Dell Software

Our Relative Abundance Results Across ~300 People Show Why Dell Analytics Tree Classifier Works UC 100x Healthy LS 100x UC We Produced Similar Results for ~2500 Microbial Species Healthy 100x CD

Ileal Crohn’s and UC Patients Have Reduced Abundance of Anti-Inflammatory Faecalibacterium prausnitzii However, Colonic Crohn’s (LS) Have Increased Abundance

feces ileum biopsies distal colon biopsies Faecalibacterium prausnitzii One of the main producers of butyrate Important for colonic health. Willing et al., 2009.Inflammatory Bowel Diseases A Noninvasive Diagnostic?? - Faecalibacterium is Depleted in Ileal CD and Increased in Colonic CD Slide from Janet Jansson, PNNL

Is the Gut Microbial Ecology Different in Crohn’s Disease Subtypes? Ben Willing, GASTROENTEROLOGY 2010;139:1844 –1854 Colonic Crohn’s Disease (CCD) Ileal Crohn’s Disease (ICD)

It Appears That Metabolomics Can Differentiate Ileum vs. Colon Inflammation in Crohn’s Disease blue N= Ileum (ICD) red N= Colon (CCD) green N= Healthy Jansson, et al. PLOS ONE, July 2009 | Volume 4 | Issue 7 | e6386

In a “Healthy” Gut Microbiome: Large Taxonomy Variation, Low Protein Family Variation Source: Nature, 486, (2012) Over 200 People

Ratio of One of the Healthy Subjects to the Average KEGG for 35 Healthy: Test to see How Much Inter-Personal Variation There is Within Healthy Most KEGGs Are Within 10x Of Healthy for a Random HE Ratio of Random HE11529 to Healthy Average for Each Nonzero KEGG Nonzero KEGGs We Computed the Relative Abundance of 10,000 KEGGs in 35 Healthy And 25 IBD Patients

However, Our Research Shows Large Changes in Protein Families Between Health and Disease Most KEGGs Are Within 10x In Healthy and Ileal Crohn’s Disease KEGGs Greatly Increased In the Disease State KEGGs Greatly Decreased In the Disease State Over 7000 KEGGs Which Are Nonzero in Health and Disease States Ratio of CD Average to Healthy Average for Each Nonzero KEGG Note Hi/Low Symmetry Note 700 KEGGs With Ratio >10 Note 1000 KEGGs With Ratio <0.1

Can We Define a Subgroup of the 10,000 KEGGs Which Are Extreme in the Disease State? Look for KEGGs That Have the Properties: –Are 100x in All Four Disease States –LS001/Ave HE –Ave CD/ Ave HE –Ave UC/Ave HE –Sick HE Person/Ave HE There are 48 of These Extreme KEGGs (see spreadsheet) A New Way to Define What is Wrong with the Microbiome in Disease?

Using Ayasdi Interactively to Explore Protein Families in Healthy and Disease States Source: Pek Lum, Formerly Chief Data Scientist, Ayasdi Dataset from Larry Smarr Team With 60 Subjects (HE, CD, UC, LS) Each with 10,000 KEGGs - 600,000 Cells

We Found a Set of Lenes That Clearer Find the 43 Extreme KEGGs K00108(choline_dehydrogenase) K00673(arginine_N-succinyltransferase) K00867(type_I_pantothenate_kinase) K01169(ribonuclease_I_(enterobacter_ribonuclease)) K01484(succinylarginine_dihydrolase) K01682(aconitate_hydratase_2) K01690(phosphogluconate_dehydratase) K01825(3-hydroxyacyl-CoA_dehydrogenase_/_enoyl-CoA_hydratase_/3-hydroxybutyryl-CoA_epimerase_/_enoyl-CoA_isomerase_[EC: _ _ ]) K02173(hypothetical_protein) K02317(DNA_replication_protein_DnaT) K02466(glucitol_operon_activator_protein) K02846(N-methyl-L-tryptophan_oxidase) K03081(3-dehydro-L-gulonate-6-phosphate_decarboxylase) K03119(taurine_dioxygenase) K03181(chorismate--pyruvate_lyase) K03807(AmpE_protein) K05522(endonuclease_VIII) K05775(maltose_operon_periplasmic_protein) K05812(conserved_hypothetical_protein) K05997(Fe-S_cluster_assembly_protein_SufA) K06073(vitamin_B12_transport_system_permease_protein) K06205(MioC_protein) K06445(acyl-CoA_dehydrogenase) K06447(succinylglutamic_semialdehyde_dehydrogenase) K07229(TrkA_domain_protein) K07232(cation_transport_protein_ChaC) K07312(putative_dimethyl_sulfoxide_reductase_subunit_YnfH_(DMSO_reductaseanchor_subunit)) K07336(PKHD-type_hydroxylase) K08989(putative_membrane_protein) K09018(putative_monooxygenase_RutA) K09456(putative_acyl-CoA_dehydrogenase) K09998(arginine_transport_system_permease_protein) K10748(DNA_replication_terminus_site-binding_protein) K11209(GST-like_protein) K11391(ribosomal_RNA_large_subunit_methyltransferase_G) K11734(aromatic_amino_acid_transport_protein_AroP) K11735(GABA_permease) K11925(SgrR_family_transcriptional_regulator) K12288(pilus_assembly_protein_HofM) K13255(ferric_iron_reductase_protein_FhuF) K14588() K15733() K15834() L-Infinity Centrality Lens Using Norm Correlation as Metric (Resolution: 242, Gain: 5.7) Entropy & Variance Lens Using Angle as Metric (Resolution: 30, Gain 3.00) Analysis by Mehrdad Yazdani, Calit2

Disease Arises from Perturbed Protein Family Networks: Dynamics of a Prion Perturbed Network in Mice Source: Lee Hood, ISB 32 Our Next Goal is to Create Such Perturbed Networks in Humans

Next Step: Compute Genes and Function For All ~300 People’s Gut Microbiome Full Processing to Function: Genes & Protein Families (COGs, KEGGs) Would Require ~1-2 Million Core-Hours

UC San Diego Will Be Carrying Out a Major Clinical Study of IBD Using These Techniques Inflammatory Bowel Disease Biobank For Healthy and Disease Patients Drs. William J. Sandborn, John Chang, & Brigid Boland UCSD School of Medicine, Division of Gastroenterology Already 185 Enrolled, Goal is 1500 Announced November 7, 2014!

Thanks to Our Great Team! UCSD Metagenomics Team Weizhong Li Sitao Wu Future Patient Team Jerry Sheehan Tom DeFanti Kevin Patrick Jurgen Schulze Andrew Prudhomme Philip Weber Fred Raab Joe Keefe Ernesto Ramirez JCVI Team Karen Nelson Shibu Yooseph Manolito Torralba SDSC Team Michael Norman Ilkay Altintas Shweta Purawat Mahidhar Tatineni Robert Sinkovits UCSD Health Sciences Team William J. Sandborn Elisabeth Evans John Chang Brigid Boland David Brenner Dell/R Systems and Dell Analytics Brian Kucic John Thompson Tom Hill